Journals
Books
Articles by keyword гепарин
Perspectives on Quality and Safety of Medicines on the Basis of Low Molecular Weight Heparin
E.A. Arianova, M.N. Bogachuk, O.I. Perederyaev
Abnormalities of Haemostasis in Cancer Patients with Thrombosis and Thromboembolic of Pulmonary Artery, which Occurred During Subacute Disseminated Intravascular Coagulation
O.V. Somonova, A.V. Madzhuga, A.L. Elizarova
Prevention of abnormalities of hemostasis and vte in ovarian cancer patients, undergoing chemotherapy
O.V. Somonova, A.V. Madzhuga, A.L. Elizarova, D.N. Kushlinskii, I.I. Matveeva
Abnormalities of hemostasis and vte in cancer patients
O.V. Somonova, A.V. Madzhuga, A.L. Elizarova
Low molecular weight heparins for the prevention and therapy thrombotic complication in oncological patients
O.V. Somonova - Dr.Sc.(Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
A.V. Madzhuga - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
A.L. Elizarova - Ph.D. (Biol.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
I.I. Matveeva - Dr.Sc.(Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
Thrombotic complications in patients with kidney cancer and their prevention

O.V. Somonova – 

Dr. Sc. (Med.), Professor, Department of Clinical Biochemistry and Laboratory Diagnostics, 

A.I. Evdokimova Moscow State Medical and Dental University 

E-mail: somonova@mail.ru S.L. Teodorovich – oncologist, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

A.L. Elizarova – 

Ph.D. (Biol.), Senior Research Scientist, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

E-mail: anna_el@rambler.ru N.E. Kushlinskii – 

Ph.D. (Med.), Professor, Corresponding member of RAS, Head of the Department of Clinical Biochemistry 

and Laboratory Diagnostics, A.I. Evdokimov Moscow State Medical and Dental University E-mail: biochimia@yandex.ru

Possibilities of using parnaparin sodium in oncology

O.V. Somonova1, A.L. Elizarova2, A.V. Sytov3, M.I. Timoshkov4, I.V. Babkina5, M.A. Kononov6

1–3,5,6 N.N. Blokhin National Medical Research Center of Oncology
of the Ministry of Health of the Russian Federation (Moscow, Russia)

4 G.B. Mirzoev Russian University of Advocacy and Notariate (Moscow, Russia)

1 somonova@mail.ru, 2 anna_el@rambler.ru, 3 drsytov@rambler.ru, 5 docbabkina@rambler.ru